Multi-institution Analysis of Concurrent Chemoradiation Therapy With Cisplatin (CDDP) Versus Cetuximab (C225) in Locally-Advanced Squamous Cell Carcinoma of the Head and Neck (LA-HNSCC): Can HPV Help Decide Which Agent?

被引：0
|
作者：
Riaz, N. [1 ]
Baschnagel, A. [2 ]
Adkins, D. [3 ]
Rao, S. [1 ]
Huang, J. [3 ]
Chen, P. [2 ]
Ley, J. [3 ]
Krauss, D. [2 ]
Thorstad, W. [3 ]
Lee, N. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Beaumont Hosp, Royal Oak, MI USA
[3] Washington Univ, St Louis, MO USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2013年 / 87卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2013.06.204
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S78 / S79
页数：2
相关论文
共 32 条
  • [31] Clinical response rate at primary tumor site (PTS) following a novel induction chemotherapy (IC) regimen of weekly nanoparticle albumin-bound (nab-)paclitaxel and cetuximab with every-3-week cisplatin and 5-FU (ACCF) versus docetaxel, cisplatin, 5-FU, and cetuximab (TPF plus C) in patients with locally advanced head and neck squamous cell carcinoma (HNSCC).
    Adkins, D.
    Ley, J.
    Nussenbaum, B.
    Diaz, J.
    Paniello, R.
    Thorstad, W. L.
    Gay, H. A.
    Subramanian, J.
    Wildes, T. M.
    Mathai, J.
    Rachocki, T.
    Kuperman, D. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [32] Cetuximab/Radiation Therapy (CET+RT) Versus Concomitant Chemoradiation Therapy (cCHT+RT) With or Without Induction Docetaxel/Cisplatin/5Fluorouracil (TPF) in Locally Advanced Head-and-Neck Squamous Cell Carcinoma (LASCCHN) - Preliminary Results on Toxicity of a Randomized, 2x2 Factorial, Phase II-III Study (NCT01086826)
    Ghi, M.
    Paccagnella, A.
    Orecchia, R.
    Parisi, S.
    Bertoni, F.
    Minguzzi, N.
    Baggio, V.
    Turcato, G.
    Polsinelli, M.
    Floriani, I.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S153 - S153
1234